Q3 2025 · 13F-HR
BML Capital Management, LLCholdings as filed
Filed 2025-11-10 · accession 0001754960-25-000762
$109.2M
Reported value
20
Positions
2025-09-30
Period end
The Brief · BML Capital Management, LLC · Q3 2025
AI · grounded in 13F
BML Capital Management, LLC established a new position in ACRS valued at $27.08M. The fund also initiated new stakes in AVIR for $21.67M and AVU0 for $13.85M. Additional new positions include TIL, ORMP, and PMVP. The fund ended the period with 20 positions and total AUM of $109.22M.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 00461U105 | ACRS | ACLARIS THERAPEUTICS INC | $27.1M | 24.8% | 14,250,000 | Common | NONE |
| 04683R106 | AVIR | ATEA PHARMACEUTICALS INC | $21.7M | 19.8% | 7,473,963 | Common | NONE |
| 00773U207 | AVU0 | ADVERUM BIOTECHNOLOGIES INC | $13.9M | 12.7% | 3,057,526 | Common | NONE |
| 45783C200 | TIL | INSTIL BIO INC | $11.5M | 10.6% | 645,600 | Common | NONE |
| 68403P203 | ORMP | ORAMED PHARMACEUTICALS INC | $8.4M | 7.66% | 3,167,231 | Common | NONE |
| 69353Y103 | PMVP | PMV PHARMACEUTICALS INC | $7.4M | 6.78% | 5,292,000 | Common | NONE |
| 022307102 | ALMS | ALUMIS INC | $4.8M | 4.42% | 1,210,415 | Common | NONE |
| N51517105 | 4PKB | LAVA THERAPEUTICS NV | $3.1M | 2.81% | 1,970,610 | Common | NONE |
| 49372L209 | 2KZ0 | KEZAR LIFE SCIENCES INC | $2.8M | 2.57% | 720,787 | Common | NONE |
| G23549101 | CNTB | CONNECT BIOPHARMA HLDGS LTD | $1.9M | 1.75% | 1,267,500 | Common | NONE |
| 45175G207 | IMA | IMAGENEBIO INC | $1.5M | 1.36% | 182,509 | Common | NONE |
| 04746L203 | LONA | ATHIRA PHARMA INC | $1.3M | 1.22% | 323,066 | Common | NONE |
| 046484309 | ASTC | ASTROTECH CORP | $1.1M | 0.99% | 220,410 | Common | NONE |
| 87612E106 | TGT | TARGET CORP | $897,000 | 0.82% | 10,000 | Common | NONE |
| 92840H400 | VTGN | VISTAGEN THERAPEUTICS INC | $532,500 | 0.49% | 150,000 | Common | NONE |
| 931142103 | WMT | WALMART INC | $518,738 | 0.47% | 265 | PUT | NONE |
| 04335A105 | ARVN | ARVINAS INC | $426,000 | 0.39% | 50,000 | Common | NONE |
| 128058302 | LSTA | LISATA THERAPEUTICS INC | $287,783 | 0.26% | 109,841 | Common | NONE |
| G63365103 | MURA | MURAL ONCOLOGY PUB LTD CO | $119,025 | 0.11% | 57,500 | Common | NONE |
| 88427A107 | — | THIRD HARMONIC BIO INC | $0 | — | 3,824,417 | Common | NONE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.